Clearmind Medicine Inc. financial data

Symbol: CMND on Nasdaq
Industry: Pharmaceutical Preparations
Location: 101 1220 West 6 Th Avenue, Vancouver, British Columbia, Canada (Federal Level)
State of incorporation: Canada (Federal Level)
Fiscal year end: October 31
Latest financial report: Q4 2023 - Mar 19, 2024

Shares

Label	TTM Value / Value	Unit	Change %	End date	Recent period
Entity Common Stock, Shares Outstanding	607K	shares	-54%	Oct 31, 2023	Q3 2023

Income Statement

Label	TTM Value / Value	Unit	Change %	End date	Recent period
Research And Development Expense	227K	USD	-61.3%	Jan 31, 2024	Q4 2023
General And Administrative Expense	1.16M	USD	-7.14%	Jan 31, 2024	Q4 2023

Balance Sheet

Label	TTM Value / Value	Unit	Change %	End date	Recent period
Assets	10.1M	USD		Jan 31, 2024	Q4 2023
Liabilities	5.06M	USD		Jan 31, 2024	Q4 2023

Popular Metrics

Label	TTM Value / Value	Unit	Change %	End date	Recent period
Interest Expense	19.7K	CAD		Oct 31, 2022	Q3 2022